Information: Dieses ist nicht die aktuellste Version des Datenmodells. Eine Versionsübersicht finden Sie links unter Versionen. Die aktuellste Version finden Sie hier.
Information:
Fel:
ID
34573
Beskrivning
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02240238
Länk
https://clinicaltrials.gov/show/NCT02240238
Nyckelord
Versioner (3)
- 19.01.19 19.01.19 -
- 28.09.20 28.09.20 -
- 01.10.20 01.10.20 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
19. Januar 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Solid Tumors NCT02240238
Eligibility Solid Tumors NCT02240238
- StudyEvent: Eligibility
Similar models
Eligibility Solid Tumors NCT02240238
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
(part 1 only) have a histologically or cytologically confirmed diagnosis of advanced solid tumor that has relapsed or is refractory to standard curative or palliative therapy or has a contraindication to standard therapy.
boolean
ID.2
Item
(part 2 only) have histologically or cytologically confirmed diagnosis of stage iiib or iv nsclc and have received 1 or 2 lines of prior chemotherapy or targeted therapy for stage iiib or iv nsclc (second- or third-line).
boolean
ID.3
Item
have measurable disease per response evaluation criteria in solid tumors (recist) version 1.1.
boolean
ID.4
Item
eastern cooperative oncology group (ecog) performance status of 0 to 1
boolean
ID.5
Item
have adequate bone marrow reserve, liver function, and renal function
boolean
ID.6
Item
have received prior platinum therapy in the past 3 months
boolean
ID.7
Item
have received prior cisplatin and gemcitabine concomitantly within the last 6 months or are refractory to cisplatin and gemcitabine.
boolean
ID.8
Item
unresolved toxicity from prior radiation, chemotherapy, or other targeted treatment, including investigational treatment
boolean
ID.9
Item
pregnant or breast feeding
boolean